Australia - English - Department of Health (Therapeutic Goods Administration)

fit-bioceuticals pty ltd - bromelains, quantity: 3.6 million pu; protease, quantity: 200 thousand hut; quercetin dihydrate, quantity: 500 mg; ascorbic acid, quantity: 166.66 mg; pyridoxal 5-phosphate monohydrate, quantity: 7.84 mg (equivalent: pyridoxine, qty 5 mg); hesperidin, quantity: 100 mg; rutoside, quantity: 133.33 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; microcrystalline cellulose; hypromellose; calcium hydrogen phosphate dihydrate; dextrin; povidone; macrogol 8000; colloidal anhydrous silica; carnauba wax; crospovidone; chlorophyllin-copper complex; magnesium stearate; maltodextrin - antioxidant/reduce free radicals formed in the body ; maintain/support collagen formation ; anti-inflammatory/relieve inflammation ; helps decrease/reduce/relieve symptoms of mild allergies ; maintain/support healthy immune system function ; maintain/support wound healing

United States - English - NLM (National Library of Medicine)

flon laboratories llc - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r) - ascorbic acid 500 mg in 1 ml - ascorbic acid is recommended for the prevention and treatment of scurvy. its parenteral administration is desirable for patients with an acute deficiency or for those whose absorption of orally ingested ascorbic acid is uncertain. symptoms of mild deficiency may include faulty bone and tooth development, gingivitis, bleeding gums, and loosened teeth. febril states, chronic illness, and infection (pneumonia, whooping cough, tuberculosis, diphtheria, sinusitis, rheumatic fever, etc.) increases the need for ascorbic acid. hemovascular disorders, burns, delayed fracture and wound healing are indications for an increase in the daily intake. there are no contraindications to the administration of ascorbic acid

United States - English - NLM (National Library of Medicine)

raw materials international overseas llc - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r) - ascorbic acid 500 mg in 1 ml - ascorbic acid is recommended for the prevention and treatment of scurvy. its parenteral administration is desirable for patients with an acute deficiency or for those whose absorption of orally ingested ascorbic acid is uncertain. symptoms of mild deficiency may include faulty bone and tooth development, gingivitis, bleeding gums, and loosened teeth. febrile states, chronic illness, and infection (pneumonia, whooping cough, tuberculosis, diphtheria, sinusitis, rheumatic fever, etc.) increases the need for ascorbic acid. hemovascular disorders, burns, delayed fracture and wound healing are indications for an increase in the daily intake. there are no contraindications to the administration of ascorbic acid.

Kenya - English - Pharmacy and Poisons Board

dawa limited p.o. box 16633-00620 nairobi,kenya - ascorbic acid - chewable tablet - ascorbic acid 100mg per tablet. - plain ascorbic acid (vitamin c)

Kenya - English - Pharmacy and Poisons Board

dawa limited p.o. box 16633-00620 nairobi, kenya - ascorbic acid - chewable tablet - ascorbic acid 250mg per tablet - plain ascorbic acid (vitamin c)

Kenya - English - Pharmacy and Poisons Board

dawa limited p.o. box 16633-00620 nairobi, kenya - ascorbic acid - chewable tablet - ascorbic acid 500mg per tablet - plain ascorbic acid (vitamin c)

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

healthcare pharma ltd - ascorbic acid - oral tablet - 100mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

dalkeith laboratories ltd - ascorbic acid - oral tablet - 50mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

dalkeith laboratories ltd - ascorbic acid - oral tablet - 100mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

crescent pharma ltd - ascorbic acid - oral tablet - 100mg